Cited by 203

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/fl mice

Lilla, Jennifer N., Chen, Ching-Cheng, Mukai, Kaori, BenBarak, Maya J., Franco, Christopher B., Kalesnikoff, Janet, Yu, Mang, Tsai, Mindy, Piliponsky, Adrian M., Galli, Stephen J.·2011·Blood

Abstract

It has been reported that the intracellular antiapoptotic factor myeloid cell leukemia sequence 1 (Mcl-1) is required for mast cell survival in vitro, and that genetic manipulation of Mcl-1 can be used to delete individual hematopoietic cell populations in vivo. In the present study, we report the generation of C57BL/6 mice in which Cre recombinase is expressed under the control of a segment of the carboxypeptidase A3 (Cpa3) promoter. C57BL/6-Cpa3-Cre; Mcl-1fl/fl mice are severely deficient in mast cells (92%-100% reduced in various tissues analyzed) and also have a marked deficiency in basophils (58%-78% reduced in the compartments analyzed), whereas the numbers of other hematopoietic cell populations exhibit little or no changes. Moreover, Cpa3-Cre; Mcl-1fl/fl mice exhibited marked reductions in the tissue swelling and leukocyte infiltration that are associated with both mast cell- and IgE-dependent passive cutaneous anaphylaxis (except at sites engrafted with in vitro–derived mast cells) and a basophil- and IgE-dependent model of chronic allergic inflammation, and do not develop IgE-dependent passive systemic anaphylaxis. Our findings support the conclusion that Mcl-1 is required for normal mast cell and basophil development/survival in vivo in mice, and also suggest that Cpa3-Cre; Mcl-1fl/fl mice may be useful in analyzing the roles of mast cells and basophils in health and disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2011-03-343962

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 37

  1. Kozopas, 1993, MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2., Proc Natl Acad Sci U S A, 90, 3516, 10.1073/pnas.90.8.3516 · DOI
  2. Dzhagalov, 2008, The anti-apoptotic Bcl-2 family member Mcl-1 promotes T lymphocyte survival at multiple stages., J Immunol, 181, 521, 10.4049/jimmunol.181.1.521 · DOI
  3. Dzhagalov, 2007, The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages., Blood, 109, 1620, 10.1182/blood-2006-03-013771 · DOI
  4. Opferman, 2003, Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1., Nature, 426, 671, 10.1038/nature02067 · DOI
  5. Steimer, 2009, Selective roles for antiapoptotic MCL-1 during granulocyte development and macrophage effector function., Blood, 113, 2805, 10.1182/blood-2008-05-159145 · DOI
  6. Zhou, 1998, Mcl-1 in transgenic mice promotes survival in a spectrum of hematopoietic cell types and immortalization in the myeloid lineage., Blood, 92, 3226, 10.1182/blood.V92.9.3226.421k49_3226_3239 · DOI
  7. Aichberger, 2007, Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy., Eur J Clin Invest, 37, 808, 10.1111/j.1365-2362.2007.01859.x · DOI
  8. Berent-Maoz, 2008, TRAIL mediated signaling in human mast cells: the influence of IgE-dependent activation., Allergy, 63, 333, 10.1111/j.1398-9995.2007.01598.x · DOI
  9. Wedemeyer, 2000, Roles of mast cells and basophils in innate and acquired immunity., Curr Opin Immunol, 12, 624, 10.1016/S0952-7915(00)00154-0 · DOI
  10. Kawakami, 2002, Regulation of mast cell and basophil function and survival by IgE., Nat Rev Immunol, 2, 773, 10.1038/nri914 · DOI
  11. Marone, 2005, Role of human mast cells and basophils in bronchial asthma., Adv Immunol, 88, 97, 10.1016/S0065-2776(05)88004-6 · DOI
  12. Crivellato, 2010, Mast cells and basophils: a potential link in promoting angiogenesis during allergic inflammation., Int Arch Allergy Immunol, 151, 89, 10.1159/000235998 · DOI
  13. Didichenko, 2008, IL-3 induces a Pim1-dependent antiapoptotic pathway in primary human basophils., Blood, 112, 3949, 10.1182/blood-2008-04-149419 · DOI
  14. Reynolds, 1989, Isolation and molecular cloning of mast cell carboxypeptidase A. A novel member of the carboxypeptidase gene family., J Biol Chem, 264, 20094, 10.1016/S0021-9258(19)47223-2 · DOI
  15. Serafin, 1987, Carboxypeptidase A in mouse mast cells. Identification, characterization, and use as a differentiation marker., J Immunol, 139, 3771, 10.4049/jimmunol.139.11.3771 · DOI
  16. Voehringer, 2004, Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production., Immunity, 20, 267, 10.1016/S1074-7613(04)00026-3 · DOI
  17. Feyerabend, 2009, Deletion of Notch1 converts pro-T cells to dendritic cells and promotes thymic B cells by cell-extrinsic and cell-intrinsic mechanisms., Immunity, 30, 67, 10.1016/j.immuni.2008.10.016 · DOI
  18. Franco, 2010, Distinguishing mast cell and granulocyte differentiation at the single-cell level., Cell Stem Cell, 6, 361, 10.1016/j.stem.2010.02.013 · DOI
  19. Piliponsky, 2010, Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice., Am J Pathol, 176, 926, 10.2353/ajpath.2010.090342 · DOI
  20. Galli, 1984, Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice., Science, 226, 710, 10.1126/science.6494907 · DOI
  21. Ugajin, 2009, Basophils preferentially express mouse mast cell protease 11 among the mast cell tryptase family in contrast to mast cells., J Leukoc Biol, 86, 1417, 10.1189/jlb.0609400 · DOI
  22. Wershil, 1991, Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha., J Clin Invest, 87, 446, 10.1172/JCI115016 · DOI
  23. Liu, 1980, Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization., J Immunol, 124, 2728, 10.4049/jimmunol.124.6.2728 · DOI
  24. Mukai, 2005, Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells., Immunity, 23, 191, 10.1016/j.immuni.2005.06.011 · DOI
  25. Metz, 2011, Evidence that the endothelin A receptor can enhance IgE-dependent anaphylaxis in mice., J Allergy Clin Immunol, 128, 424, 10.1016/j.jaci.2011.04.012 · DOI
  26. Kalesnikoff, 2001, Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival., Immunity, 14, 801, 10.1016/S1074-7613(01)00159-5 · DOI
  27. Zon, 1991, GATA-binding transcription factors in mast cells regulate the promoter of the mast cell carboxypeptidase A gene., J Biol Chem, 266, 22948, 10.1016/S0021-9258(18)54446-X · DOI
  28. Muzumdar, 2007, A global double-fluorescent Cre reporter mouse., Genesis, 45, 593, 10.1002/dvg.20335 · DOI · Paper page
  29. Grimbaldeston, 2005, Mast cell-deficient W-sash c-kit mutant KitW-sh/W-sh mice as a model for investigating mast cell biology in vivo., Am J Pathol, 167, 835, 10.1016/S0002-9440(10)62055-X · DOI · Paper page
  30. Kung, 1995, Mast cells modulate allergic pulmonary eosinophilia in mice., Am J Respir Cell Mol Biol, 12, 404, 10.1165/ajrcmb.12.4.7695919 · DOI
  31. Takeda, 1997, Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice., J Exp Med, 186, 449, 10.1084/jem.186.3.449 · DOI
  32. Williams, 2000, Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice., J Exp Med, 192, 455, 10.1084/jem.192.3.455 · DOI
  33. Nigrovic, 2008, Genetic inversion in mast cell-deficient Wsh mice interrupts corin and manifests as hematopoietic and cardiac aberrancy., Am J Pathol, 173, 1693, 10.2353/ajpath.2008.080407 · DOI · Paper page
  34. Zhou, 2007, Mast cell deficiency in KitW-sh mice does not impair antibody-mediated arthritis., J Exp Med, 204, 2797, 10.1084/jem.20071391 · DOI
  35. Brown, 1982, Ablation of immunity to Amblyomma americanum by anti-basophil serum: cooperation between basophils and eosinophils in expression of immunity to ectoparasites (ticks) in guinea pigs., J Immunol, 129, 790, 10.4049/jimmunol.129.2.790 · DOI · Paper page
  36. Obata, 2007, Basophils are essential initiators of a novel type of chronic allergic inflammation., Blood, 110, 913, 10.1182/blood-2007-01-068718 · DOI
  37. Kitamura, 1978, Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation., Blood, 52, 447, 10.1182/blood.V52.2.447.bloodjournal522447 · DOI

Cited by

Sorted by citations

See all 203

Metadata

Authors
Lilla, J. N., Chen, C.-C., Mukai, K., BenBarak, M. J., Franco, C. B., Kalesnikoff, J., Yu, M., Tsai, M., Piliponsky, A. M., & Galli, S. J.
Venue
Blood
Published
2011-12-22
Volume
118
Issue
26
Pages
6930-6938
ISSN
  • 0006-4971
  • 1528-0020
Cited by
203
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review